“We are at such a turning point,” said Biree Andemariam, the Chief Medical Officer of the SCDAA in an article published by The Washington Post on December 3rd, 2018. The article details the benefits gene therapies can have on on the sickle cell disease and those affected by it. Click here to read the full article!
